TrialAntimicrobial agents and chemotherapy2019

Safety, Tolerability, Pharmacokinetics, and Drug Interaction Potential of SPR741, an Intravenous Potentiator, after Single and Multiple Ascending Doses and When Combined with β-Lactam Antibiotics in Healthy Subjects.

Paul B Eckburg et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.